IPNA Scientific Workshop

IPNA Guidelines Workshop

Evidence-based Clinical Management in Pediatric Nephrology, an IPNA Scientific Workshop, is scheduled on March 30-31, 2021 in Taipei, Taiwan.

Dear Colleagues,


We cordially invite you to attend the IPNA workshop “Evidence-based Clinical Management in Pediatric Nephrology”

Evidence-based clinical management in pediatric nephrology is a challenging and major goal of our Society. IPNA has successfully begun a new initiative with the aim of developing “IPNA Clinical Practice Recommendations (IPNA-CPR)”, addressing important global topics in the field of pediatric nephrology. The first IPNA-CPR on steroid resistant nephrotic syndrome will be published soon in Pediatric Nephrology.

CPR-development follows a structured process and there is a great need for information on guideline methodology as expressed by the IPNA Regional Societies. In addition, the awareness of physicians, patients and their families of existing guidelines as well as their implementation is far from optimal.

To address this, the Best Practice and Standards Committee is organizing a scientific workshop solely dedicated to guideline methodology, distribution and implementation.

More than 20 new guidelines will be presented and discussed by international experts. We invite you to actively participate in the IPNA Workshop Agenda via submission of your abstract(s).

The scientific workshop will be held over 1 and 1/2-days with symposia, invited lectures, free oral presentations, panel discussions, and guided poster walks preceeding the 14th Asian Congress of Pediatric Nephrology. Therefore you can smoothly attend all three events.



Hotel Room Booking

Dieter Haffner

on behalf of the IPNA Best Practices & Standards Committee

Scientific committee:
Dieter Haffner, Hannover, Germany (chair) Khalid AlHasan, Riad, Kingdom of Saudi Arabia
Ali Duzova, Ankara, Turkey Olivia Boyer, Paris, France
Xu Hong, Shanghai, China Montini Giovanni, Milan, Italy
Koichi Nakanishi, Wakayama, Japan Il-Soo Ha, Seoul, Korea
Arvind Bagga, New Dehli, India Melvin Bonilla, San Juan, Puerto Rico
Pankaj Hari, New Dehli, India
Speakers :
Olivia Boyer, Paris, France Khalid Al-Hasan, Riad, KSA
Pankaj Hari, New Dehli, India Jonathan Craig, Adelaide, Australia
David Tunnicliffe, Sydney, Australia Rukshana Shroff, London, UK
Justine Bacchetta, Lyon, France Jens Drube, Hannover, Germany
Lars Pape, Hannover, Germany Allison Tong, Sydney, Australia
Keisha Gibson, Chapel Hill, US Agnes Trautmann, Heidelberg, Germany
Christoph Licht, Toronto, Canada Don Batisky, Atlanta, US
Brian Becknell, Columbus, US Giovanni Montini, Milan, Italy
Il-Soo Ha, Seoul, Korea Koichi Nakanishi, Okinawa, Japan
Arvind Bagga, New Dehli, India Francesco Emma, Rome, Italy
Karl Peter Schlingmann, Münster, Germany Detlef Böckenhauer, London, UK
Alicia Neu, Baltimore, US Franz Schaefer, Heidelberg, Germany

*Last Updated Date April 2020.

IPNA Scientific Workshop


IPNA Workshop Agenda

March 30 (Tue.)
IPNA Workshop
Venue: Shi Quan Room
Time Session Theme Speaker
08:30-08:40 Welcome
08:40-09:10 Global Needs for Guidelines

– Perspectives from low, middle and high-income countries; rare and common conditions; an IPNA survey
Olivia Boyer (France)
Khalid Al-Hasan (Saudi Arabia)
Pankaj Hari (India)
09:10-10:00 Methodology I
– Interpreting clinical trial results- confidence and magnitude versus P values
– The appraisal and synthesis of evidence for guideline development
Jonathan Craig (Australia)
David Tunnicliffe (Australia)
10:00-10:30 Coffee Break
10:30-12:10 Joined Session With Acpn Teaching Course / JMC
Guidelines I: CKD and Transplantation
– Guidelines in the management of CKD-MBD in children: learning from KDIGO, NICE and ESPN
– Clinical practice recommendations for treatment with active vitamin D analogues in children with CKD stages 2-5 and on dialysis- Position paper on the use of cinacalcet in children on dialysis: ESPN
– Clinical practice recommendations for growth hormone treatment in children with CKD: ESPN
– Recurrent disease after renal transplantation: ESPN, CERTAIN, ERKNet
* Venue changed to Chang Ching Room (10F) for this session only
Rukshana Shroff (UK)
Justine Bacchetta (France)
Jens Drube (Germany)
Lars Pape (Germany)
12:10-12:35 Methodology II
– Patient’s perspective & patient centered outcome measures: SONG initiative
Allison Tong (Australia)
12:35-13:40 Lunch and Posters
13:40-15:20 Guidelines II: Nephrotic syndrome/ HUS
– Management of Nephrotic Syndrome in Children: Recommendations from KDIGO
– IPNA Clinical Practice Recommendations for the diagnosis and management of children with steroid-resistant nephrotic syndrome
– Congenital Nephrotic Syndrome: ERKNet/ESPN consensus recommendation
– Clinical practice recommendations on the diagnosis and management of atypical HUS: HUSi
Keisha Gibson (USA)
Agnes Trautmann (Germany)
Olivia Boyer (France)
Christoph Licht (Canada)
15:20-15:50 Coffee Break
15:50-17:30 Guidelines III: Hypertension/ CAKUT
– Hypertension: The US/AAP and EU/ESH guidelines
– UTI: The North American recommendations
– UTI and VUR: The Indian recommendations
– Obstructive uropathy and renal dysplasia: ERKNet/ESPN consensus
Donald Batisky (USA)
Brian Becknell (USA)
Pankaj Hari (India)
Giovanni Montini (Italy)

March 31 (Wed.)
IPNA Workshop
Venue: Shi Quan Room
Time Session Theme Speaker
08:30-09:45 Lessons from screening programs & recent clinical trials
– Screening programs
– Clinical trials in IgA nephropathy & vasculitis
– Clinical trials in nephrotic syndrome
Il-Soo Ha (South Korea)
Koichi Nakanishi (Japan)
Arvind Bagga (India)
09:45-11:00 Guidelines IV
– Clinical practice recommendations for the diagnosis and management of X-linked hypophosphataemia
– Bartter Syndrome: Consensus/Position Paper from the ERKNet expert group for tubular disorders
– Distal renal tubular acidosis: Consensus/Position Paper from ESPN and ERKNet
Francesco Emma (Italy)
Karl Peter Schlingmann (Germany)
Detlef Böckenhauer (UK)
11:00-11:30 Coffee Break
11:30-12:20 Implementation:
– Experience from SCOPE
– Contribution from registries
Alicia Neu (USA)
Franz Schaefer (Germany)
12:00-12:30 Panel discussion: Future directions, challenges TBD
12:30-13:30 Farewell & Lunch